Non-antibiotic strategies for prevention and treatment of internalized Staphylococcus aureus
Authors:
Open Access
- 31 August 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 974984
Abstract
Staphylococcus aureus (S. aureus) infections are often difficult to cure completely. One of the main reasons for this difficulty is that S. aureus can be internalized into cells after infecting tissue. Because conventional antibiotics and immune cells have difficulty entering cells, the bacteria can survive long enough to cause recurrent infections, which poses a serious burden in healthcare settings because repeated infections drastically increase treatment costs. Therefore, preventing and treating S. aureus internalization is becoming a research hotspot. S. aureus internalization can essentially be divided into three phases: (1) S. aureus binds to the extracellular matrix (ECM), (2) fibronectin (Fn) receptors mediate S. aureus internalization into cells, and (3) intracellular S. aureus and persistence into cells. Different phases require different treatments. Many studies have reported on different treatments at different phases of bacterial infection. In the first and second phases, the latest research results show that the cell wall-anchored protein vaccine and some microbial agents can inhibit the adhesion of S. aureus to host cells. In the third phase, nanoparticles, photochemical internalization (PCI), cell-penetrating peptides (CPPs), antimicrobial peptides (AMPs), and bacteriophage therapy can effectively eliminate bacteria from cells. In this paper, the recent progress in the infection process and the prevention and treatment of S. aureus internalization is summarized by reviewing a large number of studies.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 94 references indexed in Scilit:
- The function of TLR2 during staphylococcal diseasesFrontiers in Cellular and Infection Microbiology, 2013
- Cellular Internalization Mechanism and Intracellular Trafficking of Filamentous M13 Phages Displaying a Cell-Penetrating Transbody and TAT PeptidePLOS ONE, 2012
- Adhesion Forces and Coaggregation between Vaginal Staphylococci and LactobacilliPLOS ONE, 2012
- Intracellular staphylococcus aureus: Live-in and let dieFrontiers in Cellular and Infection Microbiology, 2012
- Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical TrialsFrontiers in Cellular and Infection Microbiology, 2012
- The Role of TLR2 in Infection and ImmunityFrontiers in Immunology, 2012
- Staphylococcus aureus Protein A Binds to Osteoblasts and Triggers Signals That Weaken Bone in OsteomyelitisPLOS ONE, 2011
- Experimental Phage Therapy against Staphylococcus aureus in MiceAntimicrobial Agents and Chemotherapy, 2007
- Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cellsBiochemical Journal, 2007
- Toll-like receptors and innate immunityJournal of Molecular Medicine, 2006